>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

AGYS +11.9%, LOGI +9.4%, RTX +8.2%, MEDP +8.1%, AMRX +7.1% (guidance), MATX +6.6% (guidance), ASPN +5.7% (guidance), GE +5.1% (also announces plans to spin off GE Vernova and GE Aerospace in 2Q24), AWI +5%, NEP +5%, FI +4.8%, CR +4%, PKX +3.7%, KREF +3.6%, MMM +3.6%, VZ +3.5%, MLI +3.4%, CLF +3.3%, SHW +3%, SMPL +2.9%, CNC +2.6%, KO +2.4%, NEE +2.4%, IPAR +2.3% (guidance), IBTX +2%, ARCC +2%, BANC +2%, BRO +1.9%, DOW +1.6%, XRX +1.6%, GM +1.5%, WRB +1.4%, PAC +1.2%, NUE +1.1%, HRI +1.1%, DHR +1%, ORAN +0.8%, ADM +0.8%, ARE +0.7%, PACW +0.7%, PHM +0.6%

Select crypto related names showing strength:

HUT +15.2%, CLSK +14.9%, MARA +14.7%, RIOT +13.8%, BITF +11.5%, HIVE +10.2%, BKCH +10%, BITO +9.8%, SDIG +9.1%, MSTR +9.1%, BTBT +8.2%, COIN +7.8%, BITQ +7.2%

Other news:

ASTI +58.7% (U.S. Dept of Energy encourages Ascent to submit full application)
RDFN +7.8% (APO agree to commit up to $250 mln of financing)
CRNT +5.8% (to acquire Siklu for enterprise value of $13-$15 mln; expected to be accretive to gross margins non-GAAP EPS by 2H24)
SMR +3.5% (issues statement following "misleading short-seller report")
CENX +3.2% (three-year power contract for Mt. Holly smelter)
QTRX +2% (announces new agreement to advance blood based Alzheimer's Disease detection)
AXSM +1.6% (presentation of data from its ACCORD Phase 3 clinical trial of AXS-05)
CBAY +1.4% (presents finding of Phase 3 ENHANCE study)
MSFT +0.9% (AUD$5 bln investment expanding AI in Australia)

Analyst comments: